E. Pays, B. Vanhollebeke, L. Vanhamme, F. Paturiaux-hanocq, D. P. Nolan et al., The trypanolytic factor of human serum, Nat Rev Microbiol, vol.4, pp.477-86, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00552632

G. Genovese, D. J. Friedman, M. D. Ross, L. Lecordier, P. Uzureau et al., Association of trypanolytic ApoL1 variants with kidney disease in African Americans, Science, vol.329, pp.841-846, 2010.

J. B. Kopp, G. W. Nelson, K. Sampath, R. C. Johnson, G. Genovese et al., APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy, J Am Soc Nephrol, vol.22, pp.2129-2166, 2011.
DOI : 10.1681/asn.2011040388

URL : https://jasn.asnjournals.org/content/22/11/2129.full.pdf

S. Limou, P. D. Dummer, G. W. Nelson, J. B. Kopp, and C. A. Winkler, APOL1 toxin, innate immunity, and kidney injury, Kidney Int, vol.88, pp.28-34, 2015.
DOI : 10.1038/ki.2015.109

URL : http://europepmc.org/articles/pmc4490079?pdf=render

A. N. Kasembeli, R. Duarte, M. Ramsay, P. Mosiane, C. Dickens et al., APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans, J Am Soc Nephrol, vol.26, pp.2882-90, 2015.
DOI : 10.1681/asn.2014050469

URL : https://jasn.asnjournals.org/content/26/11/2882.full.pdf

V. Shahinian, S. Rajaraman, M. Borucki, J. Grady, W. M. Hollander et al., Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients, Am J kidney Dis, vol.35, pp.884-892, 2000.

G. M. Lucas, J. A. Eustace, S. Sozio, E. K. Mentari, K. A. Appiah et al., Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study, AIDS, vol.18, pp.541-547, 2004.

N. Chandel, B. Sharma, M. Husain, D. Salhan, T. Singh et al., HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor, Am J Physiol Renal Physiol, vol.304, pp.1347-57, 2013.

T. Doyle, C. Goujon, and M. H. Malim, HIV-1 and interferons: who's interfering with whom?, Nat Rev Microbiol, vol.13, pp.403-416, 2015.
DOI : 10.1038/nrmicro3449

J. B. Kopp, J. Heymann, and C. A. Winkler, APOL1 renal risk variants: fertile soil for hiv-associated nephropathy, Semin Nephrol, vol.37, pp.514-523, 2017.
DOI : 10.1016/j.semnephrol.2017.07.004

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745063

J. Mikulak, F. Oriolo, F. Portale, P. Tentorio, X. Lan et al., Impact of APOL1 polymorphism and IL-1beta priming in the entry and persistence of HIV-1 in human podocytes, Retrovirology, vol.13, p.63, 2016.

H. E. Taylor, A. K. Khatua, and W. Popik, The innate immune factor apolipoprotein L1 restricts HIV-1 infection, J Virol, vol.88, pp.592-603, 2014.
DOI : 10.1128/jvi.02828-13

URL : http://europepmc.org/articles/pmc3911732?pdf=render

S. Limou, G. W. Nelson, J. B. Kopp, and C. A. Winkler, APOL1 kidney risk alleles: population genetics and disease associations, Adv Chronic Kidney Dis, vol.21, pp.426-459, 2014.
DOI : 10.1053/j.ackd.2014.06.005

URL : http://europepmc.org/articles/pmc4157456?pdf=render

D. Vlahov, N. Graham, D. Hoover, C. Flynn, J. G. Bartlett et al., Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count, JAMA, vol.279, pp.35-40, 1998.

P. An, P. Duggal, L. H. Wang, S. J. O'brien, S. Donfield et al., Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals, PLoS Genet, vol.3, p.19, 2007.

W. Y. Ko, P. Rajan, F. Gomez, L. Scheinfeldt, P. An et al., Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations, Am J Hum Genet, vol.93, pp.54-66, 2013.

E. Kruzel-davila, R. Shemer, A. Ofir, I. Bavli-kertselli, I. Darlyuk-saadon et al., APOL1-mediated cell injury involves disruption of conserved trafficking processes, J Am Soc Nephrol, vol.28, 2017.

M. M. Estrella, M. Li, A. Tin, A. G. Abraham, M. G. Shlipak et al., The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status, Clin Infect Dis, vol.60, pp.646-52, 2015.

J. Fellay, D. Ge, K. V. Shianna, S. Colombo, B. Ledergerber et al., Common genetic variation and the control of HIV-1 in humans, PLoS Genet, vol.5, p.1000791, 2009.

, Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome, MMWR, pp.1-15, 1987.

D. D. Celentano, N. Galai, A. K. Sethi, N. G. Shah, S. A. Strathdee et al., Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users, AIDS, vol.15, pp.1707-1722, 2001.

S. J. O'brien and G. W. Nelson, Human genes that limit AIDS, Nat Genet, vol.36, pp.565-74, 2004.

Q. J. Sattentau and M. Stevenson, Macrophages and HIV-1: an unhealthy constellation, Cell Host Microbe, vol.19, pp.304-314, 2016.
DOI : 10.1016/j.chom.2016.02.013

URL : https://doi.org/10.1016/j.chom.2016.02.013

H. Koppensteiner, R. Brack-werner, and M. Schindler, Macrophages and their relevance in Human Immunodeficiency Virus Type I infection, Retrovirology, vol.9, p.82, 2012.

V. Jotwani, M. G. Shlipak, R. Scherzer, R. S. Parekh, W. H. Kao et al., APOL1 genotype and glomerular and tubular kidney injury in women with HIV, Am J Kid Dis, vol.65, pp.889-98, 2015.

C. R. Swanepoel, M. G. Atta, D. 'agati, V. D. Estrella, M. M. Fogo et al., Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, vol.93, pp.545-59, 2018.